In contrast, we did not observe osteopenia in growing Osx-Fgfr3 mice at the age of 3 weeks, suggesting that the low bone mass observed at 3 months is independent of growth plate anomalies and is due (at least in part) to defective bone remodeling, rather than poor bone mass gain. This evidence concerns the gene FGFR3 and Osteopenia.